Lehrstuhl für Allgemein- und Viszeralchirurgie

A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article Obstructed defaecation syndrome: European consensus guidelines on the surgical management (2021) Picciariello A, O'Connell PR, Hahnloser D, Gallo G, Munoz-Duyos A, Schwandner O, Sileri P, et al. Journal article Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting (2021) Parma B, Ramesh V, Gollavilli PN, Siddiqui A, Pinna L, Schwab A, Marschall S, et al. Journal article Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease (2021) Stürzl M, Kunz M, Krug SM, Naschberger E Journal article, Review article Plasma Metabolic Profiling Identify Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma (2021) Mahajan UM, Alnatsha A, Li Q, Oehrle B, Weiss U, Sendler M, Distler M, et al. Conference contribution Muscle‐derived cytokines reduce growth, viability and migratory activity of pancreatic cancer cells (2021) Schwappacher R, Dieterich W, Reljic D, Pilarsky C, Mukhopadhyay D, Chang DK, Biankin A, et al. Journal article Pylorus-Preserving Pancreaticoduodenectomy (PPPD) with Segmental Portal Vein Resection (2021) Brunner M, Krautz C, Maak M, Weber G, Grützmann R Journal article, Editorial Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma (2021) Mahajan UM, Alnatsha A, Li Q, Oehrle B, Weiss FU, Sendler M, Distler M, et al. Journal article DYNAMIC CHANGES IN O-GLCNACYLATION REGULATE OSTEOCLAST DIFFERENTIATION AND BONE LOSS IN ARTHRITIS (2021) Chen CW, Li YN, Trinh MT, Honglin Z, Matei AE, Ding X, TRAN MANH C, et al. Conference contribution Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021) Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution